Nombre del producto:5-{2-[(tert-butoxy)carbonyl]-2-azabicyclo[2.1.1]hexan-5-yl}-1,3-oxazole-4-carboxylic acid

IUPAC Name:5-{2-[(tert-butoxy)carbonyl]-2-azabicyclo[2.1.1]hexan-5-yl}-1,3-oxazole-4-carboxylic acid

CAS:2225136-40-1
Fórmula molecular:C14H18N2O5
Pureza:95%+
Número de catálogo:CM479321
Peso molecular:294.31

Unidad de embalaje Stock disponible Precio($) Cantidad
CM479321-100mg 4-5 Weeks ǪIJŌ
CM479321-250mg 4-5 Weeks IJŮľ
CM479321-500mg 5-6 Weeks ŮŤľȃ
CM479321-1g 5-6 Weeks ŮľŤŌ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2225136-40-1
Fórmula molecular:C14H18N2O5
Punto de fusión:-
Código de sonrisas:CC(C)(C)OC(=O)N1CC2CC1C2C1=C(N=CO1)C(O)=O
Densidad:
Número de catálogo:CM479321
Peso molecular:294.31
Punto de ebullición:
Nº Mdl:MFCD31665706
Almacenamiento:

Category Infos

Oxazoles
Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.
Pyrrolidines
Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

Related Products